These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 27616754)
1. Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis. Tan X; Cao X; Zou J; Shen B; Zhang X; Liu Z; Lv W; Teng J; Ding X Hemodial Int; 2017 Apr; 21(2):161-167. PubMed ID: 27616754 [TBL] [Abstract][Full Text] [Related]
2. Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access. Wu CC; Hung SC; Kuo KL; Tarng DC Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28067862 [TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
4. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β Yamamoto S Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756 [TBL] [Abstract][Full Text] [Related]
6. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. Hung SC; Kuo KL; Wu CC; Tarng DC J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28174171 [No Abstract] [Full Text] [Related]
7. Comment on Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358. Barreto FC; Barreto DV; Stinghen AEM; Massy ZA Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28420181 [TBL] [Abstract][Full Text] [Related]
8. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease. Gao H; Liu S Life Sci; 2017 Sep; 185():23-29. PubMed ID: 28754616 [TBL] [Abstract][Full Text] [Related]
9. Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sato E; Mori T; Mishima E; Suzuki A; Sugawara S; Kurasawa N; Saigusa D; Miura D; Morikawa-Ichinose T; Saito R; Oba-Yabana I; Oe Y; Kisu K; Naganuma E; Koizumi K; Mokudai T; Niwano Y; Kudo T; Suzuki C; Takahashi N; Sato H; Abe T; Niwa T; Ito S Sci Rep; 2016 Nov; 6():36618. PubMed ID: 27830716 [TBL] [Abstract][Full Text] [Related]
10. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Lin CJ; Liu HL; Pan CF; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ Arch Med Res; 2012 Aug; 43(6):451-6. PubMed ID: 22885091 [TBL] [Abstract][Full Text] [Related]
11. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120. Niwa T Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500 [TBL] [Abstract][Full Text] [Related]
12. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship]. Kiss I Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398 [TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease. Fourdinier O; Glorieux G; Brigant B; Diouf M; Pletinck A; Vanholder R; Choukroun G; Verbeke F; Massy ZA; Metzinger-Le Meuth V; Metzinger L; Group-EUTox OBOTEUTW Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638892 [TBL] [Abstract][Full Text] [Related]
14. Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy? Yamaguchi J; Tanaka T; Inagi R Nephron; 2017; 135(3):201-206. PubMed ID: 27960172 [TBL] [Abstract][Full Text] [Related]
15. Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression. Takada T; Yamamoto T; Matsuo H; Tan JK; Ooyama K; Sakiyama M; Miyata H; Yamanashi Y; Toyoda Y; Higashino T; Nakayama A; Nakashima A; Shinomiya N; Ichida K; Ooyama H; Fujimori S; Suzuki H Sci Rep; 2018 Jul; 8(1):11147. PubMed ID: 30042379 [TBL] [Abstract][Full Text] [Related]
16. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Fujii H; Nakai K; Fukagawa M Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501 [TBL] [Abstract][Full Text] [Related]
17. Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and cats. Chen CN; Chou CC; Tsai PSJ; Lee YJ Vet J; 2018 Feb; 232():33-39. PubMed ID: 29428089 [TBL] [Abstract][Full Text] [Related]
18. Electrochemical sensing of the secretion of indoxyl sulfate in a rat intestinal loop using a self-assembled monolayer-modified gold bead electrode. Fujita K; Nonaka T; Kutsuno R; Ichida K Talanta; 2022 Sep; 247():123551. PubMed ID: 35649325 [TBL] [Abstract][Full Text] [Related]
19. The harmful effect of indoxyl sulfate on neovascularization in chronic kidney disease. Dou L; Burtey S Kidney Int; 2016 Mar; 89(3):532-4. PubMed ID: 26880447 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis. Lano G; Sallée M; Pelletier M; Bataille S; Fraisse M; McKay N; Brunet P; Dou L; Burtey S Nephrol Dial Transplant; 2022 Nov; 37(12):2528-2537. PubMed ID: 35146525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]